Immunogenicity & Bioassay Summit
October 15 – 18, 2024 // Washington D.C.
Join Worldwide Clinical Trials at the Immunogenicity & Bioassay Summit.
0
days leftAbout event
The Immunogenicity & Bioassay Summit will address resolving the challenges of immunogenicity testing and risk assessment in preclinical and clinical development, bioassay design and analysis, and strategies for leveraging the immune system for therapeutic advantage. If you are attending, stop by booth #1 and say hello to our team.
Tom Zhang, PhD, Chief Scientific Officer, Large Molecule Bioanalysis, will be giving a presentation titled “Unlocking the Potential of Bioanalytical Automation: Bridging the Gap between Development and Application” on October 17 at 2:30 P.M. EST. This presentation will highlight the following:
- Introduction to Bioanalytical Automation: Overview of the development of bioanalytical automation over the years.
- Key technological advancements and innovations in the field.
- Current State of Application: Examination of the limited application of automation in bioanalytical laboratories.
- Comparison with other fields where automation is extensively applied.
- Challenges and Barriers: Identification of major obstacles preventing widespread adoption in bioanalysis.
- Discussion on technical, regulatory, and operational challenges.
- Benefits of Automation: Potential improvements in efficiency, accuracy, and reproducibility. Impact on data integrity, compliance, and throughput.
- Case Studies and Success Stories: Examples of successful implementation of automation in bioanalytical settings. Lessons learned and best practices from these implementations.
- Future Prospects: Emerging trends and future directions for bioanalytical automation. Potential for integration with AI and machine learning for enhanced capabilities.
Date
Tuesday to Friday
October 15 – 18, 2024
Venue
The Watergate Hotel
2650 Virginia Ave NW
Washington, DC 20037
Tom Zhang, PhD
Chief Scientific Officer, Large Molecule Bioanalysis
Our large molecule bioanalytical lab is headed by Dr. Tom Zhang, industry recognized large molecule bioanalysis expert. Dr. Zhang is responsible for evaluating and recommending analytical platforms in support of quantitative large molecule work; actively promoting technical development programs to keep Worldwide at the forefront of technology in support of large molecule bioanalysis; and maintaining state-of-the-art knowledge pertaining to large molecule bioanalytical methodologies.
